Remicade and Ventricular hypertrophy - a phase IV clinical study of FDA data

Summary:

Ventricular hypertrophy is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Methotrexate, and have Arthritis.

The phase IV clinical study analyzes which people have Ventricular hypertrophy when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Ventricular hypertrophy?

Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart) is found to be associated with 698 drugs and 794 conditions by eHealthMe. Check the latest studies of Ventricular hypertrophy.

On Jul, 15, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 46 people (0.02%) have Ventricular hypertrophy.

Could Remicade cause Ventricular hypertrophy?

Among these 46 people:

How long have people been on Remicade when they have Ventricular hypertrophy? *

What is the gender of people who have Ventricular hypertrophy when taking Remicade? *

female: 65.22 %
male: 34.78 %

What is the age of people who have Ventricular hypertrophy when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Ventricular hypertrophy? *

Mitral Valve Incompetence (inefficient heart valve): 18 people, 39.13%
Cardiac Failure Congestive: 17 people, 36.96%
Aortic Valve Incompetence: 12 people, 26.09%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 12 people, 26.09%
High Blood Pressure: 11 people, 23.91%
Fatigue (feeling of tiredness): 10 people, 21.74%
Oedema Peripheral (superficial swelling): 8 people, 17.39%
Acute Kidney Failure: 8 people, 17.39%
Tricuspid Valve Incompetence (inefficient heart valve): 8 people, 17.39%
Pleural Effusion (water on the lungs): 7 people, 15.22%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 4.35%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 2.17%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 2.17%
Pain: 1 person, 2.17%
Metastases To Bone (cancer spreads to bone): 1 person, 2.17%
Menopause (end of monthly cycles in women): 1 person, 2.17%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 1 person, 2.17%
Inflammatory Bowel Disease: 1 person, 2.17%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 2.17%
High Blood Pressure: 1 person, 2.17%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Ventricular hypertrophy?

- Check whether Ventricular hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular hypertrophy:

Ventricular hypertrophy (698 drugs)

Browse all the conditions that are associated with Ventricular hypertrophy:

Ventricular hypertrophy (794 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.